NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.92
-0.03 (-0.90%)
As of Sep 28, 10:40 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,289.4% upside
Low Target $36.99
Average Target $40.57
High Target $64.99
Current Price $2.92
Current
$2.92
Target
$40.57
$36.99 $40.57 avg $64.99
Scenario Analysis
Bear Case
$36.99
1,166.8%
Low target
Base Case
$40.57
+1,289.4%
Avg target
Bull Case
$64.99
+2,125.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$24.60
-88.1% from high
52-Week Low
$1.83
+59.6% from low
Target vs 52W High
$40.57
+64.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%